4 results (0.27 seconds)  
Other interventions such as platelet-derived growth factor (becaplermin), and platelet-rich-plasma (PRP) may also be viable options. See topic "Cellular and/or ...
A 1994 small RCT (41 patients) [111] compared efficacy of the daily topical application of recombinant platelet-derived growth factor-BB (rPDGF-BB) with ...
Molecular therapy: use of vascular endothelial growth factors, VEGF-C and VEGF-D to promote lymphangiogenesis. Anti-proliferative therapy: use of octreotide ...
Autologous and recombinant biologic substances have been generated as a result of ... growth factors. Primary study outcomes were patients requiring ...
t
-->